Gene: ALDH1A1
Official Full Name: aldehyde dehydrogenase 1 family member A1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the aldehyde dehydrogenase family. Aldehyde dehydrogenase is the next enzyme after alcohol dehydrogenase in the major pathway of alcohol metabolism. There are two major aldehyde dehydrogenase isozymes in the liver, cytosolic and mitochondrial, which are encoded by distinct genes, and can be distinguished by their electrophoretic mobility, kinetic properties, and subcellular localization. This gene encodes the cytosolic isozyme. Studies in mice show that through its role in retinol metabolism, this gene may also be involved in the regulation of the metabolic responses to high-fat diet. [provided by RefSeq, Mar 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07039 | ALDH1A1 Knockout cell line (HCT 116) | Human | ALDH1A1 | 1:2~1:4 | Negative | Online Inquiry |
KO07040 | ALDH1A1 Knockout cell line (A549) | Human | ALDH1A1 | 1:3~1:4 | Negative | Online Inquiry |
ALDH1A1 Gene Knockout Cell Lines are genetically modified cell line models in which the aldehyde dehydrogenase 1 family member A1 (ALDH1A1) gene has been disrupted or knocked out. This gene is known for its pivotal role in the oxidation of aldehydes to their corresponding carboxylic acids, a vital biochemical pathway linked to numerous cellular processes including cellular differentiation, proliferation, and responses to oxidative stress. By utilizing CRISPR-Cas9 or other genome editing technologies, these knockout cell lines provide researchers with a robust tool to dissect the biological functions of ALDH1A1 and its implications in various metabolic and developmental processes.
The key functions of ALDH1A1 make these knockout cell lines particularly significant for studying a range of biological phenomena. For instance, ALDH1A1 is associated with stemness in cancer cells and plays a critical role in the detoxification of reactive aldehydes, providing insights into oncology and cellular senescence. Researchers can utilize these cell lines to explore therapeutic targets for diseases where ALDH1A1 modulation is crucial, such as in cancer treatment or neurodegenerative disorders.
In terms of advantages, these knockout cell lines offer a significant edge over conventional cell lines, where the presence of ALDH1A1 can mask or complicate experimental results. By enabling precise investigations into the absence of this key enzyme, researchers can observe phenotypical changes that directly correlate to ALDH1A1 activity. Additionally, the specificity of the knockout increases reproducibility and clarity in experiments, helping to reduce variability often seen in wild-type cell lines.
The ALDH1A1 Gene Knockout Cell Lines are thus invaluable for academic and clinical researchers alike, allowing for the advancement of pivotal discoveries in drug development and genetic research. Moreover, with our company’s commitment to high-quality genetic tools and deep expertise in genetic engineering, we provide not only these cell lines but also comprehensive support and resources to assist researchers in their innovative pursuits. Our understanding of the complexities of biological research enhances the usability and effectiveness of our products, empowering investigators to achieve groundbreaking results.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.